Location History:
- late of Yaerlose, DK (1998)
- late of V.ae butted.rl.o slashed.se, DK (1998)
- late of 3500 V.ae butted.rl.o slashed.se, DK (1998)
- late of DK 3500 Vaerlose, DK (1999)
- late of Vaerlose, DK (1999)
- late of Vaelose, DK (2000)
Company Filing History:
1 out of 1,164 
9 out of 832,880 Years Active: 1998-2000
Title: The Innovative Contributions of Ole Buchardt
Introduction
Ole Buchardt was a notable inventor whose work significantly impacted the field of peptide nucleic acids. He held a total of 10 patents, showcasing his innovative spirit and dedication to scientific advancement. His contributions have paved the way for new applications in diagnostics, research, and therapeutics.
Latest Patents
Among his latest patents, Buchardt developed histidine-containing peptide nucleic acids. These peptide nucleic acids, which include histidine moieties, have various applications, including diagnostics and potential therapeutics. Additionally, he synthesized a novel class of chiral peptide nucleic acid monomers and oligomers, incorporating chirality in the backbone, which further enhances the functionality of peptide nucleic acids.
Career Highlights
Throughout his career, Ole Buchardt worked with prominent companies, including Boehringer Mannheim GmbH. His innovative research and development efforts have made significant contributions to the scientific community, particularly in the area of peptide nucleic acids.
Collaborations
Buchardt collaborated with esteemed colleagues such as Peter Eigil Nielsen and Michael Egholm. Their combined expertise and efforts have led to advancements in the field, further solidifying Buchardt's legacy as an influential inventor.
Conclusion
Ole Buchardt's innovative work in peptide nucleic acids has left a lasting impact on the scientific community. His patents and collaborations have opened new avenues for research and potential therapeutic applications. His contributions will continue to inspire future generations of inventors and researchers.